| Anti‐inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease DND Riccia, F Bizzini, MG Perilli, A Polimeni, V Trinchieri, G Amicosante, ... Oral diseases 13 (4), 376-385, 2007 | 350 | 2007 |
| Occurrence of Extended-Spectrum β-Lactamases in Members of the Family Enterobacteriaceae in Italy: Implications for Resistance to β-Lactams and Other … T Spanu, F Luzzaro, M Perilli, G Amicosante, A Toniolo, G Fadda, ... Antimicrobial agents and chemotherapy 46 (1), 196-202, 2002 | 340 | 2002 |
| Trends in production of extended-spectrum β-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey F Luzzaro, M Mezzatesta, C Mugnaioli, M Perilli, S Stefani, G Amicosante, ... Journal of clinical microbiology 44 (5), 1659-1664, 2006 | 242 | 2006 |
| Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals G Celenza, C Pellegrini, M Caccamo, B Segatore, G Amicosante, M Perilli Journal of Antimicrobial Chemotherapy 57 (5), 975-978, 2006 | 223 | 2006 |
| Presence of the ica operon in clinical isolates of Staphylococcus epidermidis and its role in biofilm production V Cafiso, T Bertuccio, M Santagati, F Campanile, G Amicosante, ... Clinical Microbiology and Infection 10 (12), 1081-1088, 2004 | 203 | 2004 |
| CTX-M-type extended-spectrum β-lactamases in Italy: molecular epidemiology of an emerging countrywide problem C Mugnaioli, F Luzzaro, F De Luca, G Brigante, M Perilli, G Amicosante, ... Antimicrobial agents and chemotherapy 50 (8), 2700-2706, 2006 | 201 | 2006 |
| Proteus mirabilis Bloodstream Infections: Risk Factors and Treatment Outcome Related to the Expression of Extended-Spectrum β-Lactamases A Endimiani, F Luzzaro, G Brigante, M Perilli, G Lombardi, G Amicosante, ... Antimicrobial agents and chemotherapy 49 (7), 2598-2605, 2005 | 193 | 2005 |
| Molecular Characterization of Extended-Spectrum β-Lactamases Produced by Nosocomial Isolates of Enterobacteriaceae from an Italian Nationwide Survey M Perilli, E Dell'Amico, B Segatore, MR de Massis, C Bianchi, F Luzzaro, ... Journal of clinical microbiology 40 (2), 611-614, 2002 | 192 | 2002 |
| Cytotoxic Activity and Antioxidant Capacity of Purified Lichen Metabolites: An In Vitro Study F Brisdelli, M Perilli, D Sellitri, M Piovano, JA Garbarino, M Nicoletti, ... Phytotherapy research 27 (3), 431-437, 2013 | 185 | 2013 |
| Bacteremia Due to Klebsiella pneumoniae Isolates Producing the TEM-52 Extended-Spectrum β-Lactamase: Treatment Outcome of Patients Receiving Imipenem … A Endimiani, F Luzzaro, M Perilli, G Lombardi, A Colì, A Tamborini, ... Clinical Infectious Diseases 38 (2), 243-251, 2004 | 160 | 2004 |
| Nosocomial Infections Caused by Multidrug-Resistant Isolates of Pseudomonas putida Producing VIM-1 Metallo-β-Lactamase G Lombardi, F Luzzaro, JD Docquier, ML Riccio, M Perilli, A Colì, ... Journal of clinical microbiology 40 (11), 4051-4055, 2002 | 157 | 2002 |
| Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients G Brigante, F Luzzaro, M Perilli, G Lombardi, A Colì, GM Rossolini, ... International journal of antimicrobial agents 25 (2), 157-162, 2005 | 152 | 2005 |
| Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B β-lactamase showing a broad substrate profile GM Rossolini, N Franceschini, ML Riccio, PS Mercuri, M Perilli, M Galleni, ... Biochemical Journal 332 (1), 145-152, 1998 | 152 | 1998 |
| Dynamics of a Nosocomial Outbreak of Multidrug-Resistant Pseudomonas aeruginosa Producing the PER-1 Extended-Spectrum β-Lactamase F Luzzaro, E Mantengoli, M Perilli, G Lombardi, V Orlandi, A Orsatti, ... Journal of clinical microbiology 39 (5), 1865-1870, 2001 | 151 | 2001 |
| ADP-ribose polymers localized on Ctcf–Parp1–Dnmt1 complex prevent methylation of Ctcf target sites M Zampieri, T Guastafierro, R Calabrese, F Ciccarone, MG Bacalini, ... Biochemical Journal 441 (2), 645-652, 2012 | 140 | 2012 |
| Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitumβ‐lactamase genes cloned from a natural isolate and a high … J Timm, MG Perilli, C Duez, J Trias, G Orefici, L Fattorini, G Amicosante, ... Molecular microbiology 12 (3), 491-504, 1994 | 130 | 1994 |
| Parp1 Localizes within the Dnmt1 Promoter and Protects Its Unmethylated State by Its Enzymatic Activity M Zampieri, C Passananti, R Calabrese, M Perilli, N Corbi, F De Cave, ... PloS one 4 (3), e4717, 2009 | 110 | 2009 |
| First countrywide survey of acquired metallo-β-lactamases in gram-negative pathogens in Italy GM Rossolini, F Luzzaro, R Migliavacca, C Mugnaioli, B Pini, F De Luca, ... Antimicrobial agents and chemotherapy 52 (11), 4023-4029, 2008 | 94 | 2008 |
| In vitro interaction of usnic acid in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and ΔE … B Segatore, P Bellio, D Setacci, F Brisdelli, M Piovano, JA Garbarino, ... Phytomedicine 19 (3-4), 341-347, 2012 | 93 | 2012 |
| Cerium oxide nanoparticles as potential antibiotic adjuvant. Effects of CeO2 nanoparticles on bacterial outer membrane permeability P Bellio, C Luzi, A Mancini, S Cracchiolo, M Passacantando, L Di Pietro, ... Biochimica et Biophysica Acta (BBA)-Biomembranes 1860 (11), 2428-2435, 2018 | 92 | 2018 |
